Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals Read the full story

Janssen Pharmaceuticals has acquired XO1 Limited Read the full story

Kura Oncology has entered into an agreement with Janssen Pharmaceutica for an exclusive license to develop and commercialize tipifarnib in the field of oncology Read the full story

AC Immune has entered into a worldwide exclusive license agreement and research collaboration with Janssen Pharmaceuticals Read the full story

Janssen Biotech has inked a global collaboration and licensing agreement with MacroGenics. Read the full story

Halozyme Therapeutics has entered into a worldwide Collaboration and License Agreement with Janssen Biotech for the purpose of developing and commercializing products combining proprietary Janssen compounds with Halozyme's ENHANZE technology Read the full story

Galapagos has agreed with Janssen Pharmaceutica that Galapagos will regain full and unencumbered rights to the entire GPR84 program Read the full story

Astellas Pharma announced that its license agreement with Janssen Biotech, to develop and commercialize ASP015K, oral Janus Kinase (JAK) inhibitor, will end Read the full story

Atreca has entered into a strategic collaboration with Janssen Biotech in which the companies will apply Atreca’s Immune Repertoire Capture technology to autoimmune disease Read the full story